Site identification
The Context
We are fully aware that the ultimate success of a study is linked to the selection of appropriate, qualified and productive sites, which is why we put a particular emphasis on site identification.
We can take full responsibility for the initial selection of sites or combine your own database with our lists.
Our process includes a detailed evaluation of the following aspects:
- Past history of clinical study/research involvement
- Investigator competencies and experience in clinical trials and health research studies
- Availability of co-investigators and research team
- Team workload
- Ongoing competing projects
- Training of site staff in ICH-GCP, other regulatory requirements and local procedures - Site facilities and equipment
- Recruitment potential
Wherever possible we also maintain a list of backup sites in an operational state on stand-by that can be quickly initiated if additional sites or site replacements are required.
Our Solutions
Early Stage Clinical Trials / Phase II and III Clinical Trials
Late Phase Clinical Trials / Post Marketing Safety Studies
Product Value and Effectiveness in Real-world
Public Health and Social Science Research
Health News - Africa
AllAfrica News: Health and Medicine
- South Africa: What's Happening In South African News - May 19, 2022
- Africa: WHO Concerned Over Polio Outbreak in Southeastern Africa
- Eritrea: Announcement From the Ministry of Health
- Mozambique: Covid-19 and Terrorism Put EU Electoral Recommendations At Risk
- Mozambique: Covid-19 - 16 New Cases and Eight Recoveries
- Mozambique: First Polio Outbreak in 30 Years Declared in Mozambique
- Nigeria: Days After UK's Case in Traveller From Nigeria, Monkeypox Spreads to Portugal, Spain
- Nigeria: One in Seven Children Born With HIV Globally Is a Nigerian - UNAIDS
- Nigeria: Keeping Hope Alive - Waiting for an HIV Vaccine
- Gambia: Gambia Needs a Stronger Focus On Nutrition to Improve Food Security